Portal vein thrombosis after percutaneous ethanol injection for hepatocellular carcinoma: value of color Doppler sonography in distinguishing chemical and tumor thrombi
- PMID: 7717218
- DOI: 10.2214/ajr.164.5.7717218
Portal vein thrombosis after percutaneous ethanol injection for hepatocellular carcinoma: value of color Doppler sonography in distinguishing chemical and tumor thrombi
Abstract
Objective: The distinction between benign (chemical) and tumor thromboses of the portal vein after treat,ent with percutaneous injection of ethanol for hepatocellular carcinoma is crucial for the proper management of the patient. The purpose of this study was to determine whether color Doppler sonography can be used to differentiate between the two types of thrombi.
Subjects and methods: Between October 1991 and April 1994, portal vein thrombosis was detected by color Doppler sonography in 19 patients (13 men and six women 59-77 years old; mean age, 67 years) who had hepatocellular carcinomas and who had received percutaneous ethanol injection (n = 11) or percutaneous ethanol injection after transcatheter arterial embolization (n = 8). The criterion for diagnosing tumor thrombosis by color Doppler sonography was the detection of pulsatile arterial flow in the thrombus. The benign or malignant nature of the thrombosis was subsequently established by percutaneous fine-needle biopsy of the thrombus; malignant thrombosis was seen in 13 patients, and chemical thrombosis was seen in six patients.
Results: Pulsatile arterial flow in the thrombus was observed by color Doppler sonography in 12 of the 13 malignant thrombi and in none of the bland thrombi. The flow was hepatopetal in seven cases and hepatofugal in five cases. The peak systolic frequency shift ranged from 0.59 to 2.65 kHz (mean, 1.35 kHz), and the resistive index ranged from 0.37 to 0.69 (mean, 0.55). The sensitivity and the specificity of color Doppler sonography for the detection of tumor thrombosis were 92% and 100%, respectively.
Conclusion: Our study shows that color Doppler sonography is a reliable way to differentiate between chemical and tumor thromboses of the portal vein in patients with hepatocellular carcinomas treated by ethanol injection. When the sonogram shows pulsatile arterial flow within the thrombus, percutaneous biopsy of the thrombus is unnecessary. The finding is always indicative of malignant thrombosis.
Similar articles
-
Portal vein thrombosis in patients with cirrhosis: does sonographic detection of intrathrombus flow allow differentiation of benign and malignant thrombus?AJR Am J Roentgenol. 1995 Sep;165(3):573-7. doi: 10.2214/ajr.165.3.7645473. AJR Am J Roentgenol. 1995. PMID: 7645473 Clinical Trial.
-
Diagnosis of portal vein thrombosis in patients with hepatocellular carcinoma: efficacy of color Doppler sonography compared with angiography.AJR Am J Roentgenol. 1993 Jun;160(6):1279-83. doi: 10.2214/ajr.160.6.8388620. AJR Am J Roentgenol. 1993. PMID: 8388620
-
Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy.Abdom Imaging. 2006 Sep-Oct;31(5):537-44. doi: 10.1007/s00261-005-0150-x. Abdom Imaging. 2006. PMID: 16865315
-
Contrast-enhanced ultrasound in differentiating malignant from benign portal vein thrombosis in hepatocellular carcinoma.World J Gastroenterol. 2015 Aug 28;21(32):9457-60. doi: 10.3748/wjg.v21.i32.9457. World J Gastroenterol. 2015. PMID: 26327753 Free PMC article. Review.
-
[Abdominal ultrasound diagnosis].Praxis (Bern 1994). 2000 Jun 15;89(24):1061-6. Praxis (Bern 1994). 2000. PMID: 10902463 Review. German.
Cited by
-
Contrast-enhanced sonography versus biopsy for the differential diagnosis of thrombosis in hepatocellular carcinoma patients.World J Gastroenterol. 2009 May 14;15(18):2245-51. doi: 10.3748/wjg.15.2245. World J Gastroenterol. 2009. PMID: 19437565 Free PMC article.
-
Contrast-enhanced ultrasound for the characterization of portal vein thrombosis vs tumor-in-vein in HCC patients: a systematic review and meta-analysis.Eur Radiol. 2020 May;30(5):2871-2880. doi: 10.1007/s00330-019-06649-z. Epub 2020 Feb 4. Eur Radiol. 2020. PMID: 32020403 Free PMC article.
-
Ethanol injection for the treatment of hepatic tumours.Eur Radiol. 1996;6(5):682-96. doi: 10.1007/BF00187673. Eur Radiol. 1996. PMID: 8934135 Review.
-
The Role of Contrast-Enhanced Ultrasound (CEUS) in the Detection of Neoplastic Portal Vein Thrombosis in Patients with Hepatocellular Carcinoma.Tomography. 2023 Oct 20;9(5):1976-1986. doi: 10.3390/tomography9050154. Tomography. 2023. PMID: 37888746 Free PMC article. Review.
-
Management of portal vein thrombosis in cirrhotic patients.Mediterr J Hematol Infect Dis. 2009 Nov 25;1(3):e2009014. doi: 10.4084/MJHID.2009.014. Mediterr J Hematol Infect Dis. 2009. PMID: 21415954 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous